CTRL Therapeutics USA, Inc. — Form D
CTRL Therapeutics USA, Inc. of GLENCOE, IL, a company, filed a Form D exempt-offering notice with the SEC on 2022-10-27. The offering totals $10.6M, of which $7.5M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2022-10-27
- Form: D
- Accession: 0001951690-22-000001
- Industry: Biotechnology
- Exemptions: 06b
- Total offering: $10.6M
- Amount sold: $7.5M
- Remaining: $3.1M
- Investors: 7
- Date of first sale: 2022-10-12
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-463055
Issuer
- Name: CTRL Therapeutics USA, Inc.
- CIK: 0001951690
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2022
- Address: 655 SHERIDAN RD, GLENCOE, IL, 60022
- Phone: 415-640-8884
Officers, directors & promoters (8)
| Name | Role | Location |
|---|
| Michael Kalos | Director | Glencoe, IL |
| Elena Viboch | Director | Menlo Park, CA |
| Derrell Porter | Director | Glencoe, IL |
| Derrell Porter | Executive Officer | Glencoe, IL |
| Collin Todd | Director | Glencoe, IL |
| David O'Neill | Director | London, X0 |
| Shana Kelley | Director | Glencoe, IL |
| Shana Kelley | Executive Officer | Glencoe, IL |
Other filings by this issuer (1)
More